Signature Resources Capital Management, LLC Gilead Sciences, Inc. Transaction History
Signature Resources Capital Management, LLC
- $183 Billion
- Q3 2025
A detailed history of Signature Resources Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Signature Resources Capital Management, LLC holds 173 shares of GILD stock, worth $21,467. This represents 0.01% of its overall portfolio holdings.
Number of Shares
173
Previous 178
2.81%
Holding current value
$21,467
Previous $19.7 Million
2.7%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
2,372Shares Held
1.01BCall Options Held
8.63MPut Options Held
7.39M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...